Annual CFO
-$4.00 M
+$961.20 K+19.37%
01 June 2024
Summary:
Regencell Bioscience Holdings Limited annual cash flow from operations is currently -$4.00 million, with the most recent change of +$961.20 thousand (+19.37%) on 01 June 2024. During the last 3 years, it has fallen by -$3.23 million (-421.53%). RGC annual CFO is now -923.45% below its all-time high of -$391.00 thousand, reached on 30 June 2019.RGC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RGC Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.4% | - | - |
| 3 y3 years | -421.5% | - | - |
| 5 y5 years | -923.5% | - | - |
RGC Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -421.5% | +24.0% | ||||
| 5 y | 5 years | -923.5% | +24.0% | ||||
| alltime | all time | -923.5% | +24.0% |
Regencell Bioscience Holdings Limited Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | -$4.00 M(-19.4%) | - | - |
| June 2023 | -$4.96 M(-5.8%) | - | - |
| June 2022 | -$5.27 M(+586.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | -$767.30 K(+5.6%) | - | - |
| June 2020 | -$726.60 K(+85.8%) | - | - |
| June 2019 | -$391.00 K | - | - |
FAQ
- What is Regencell Bioscience Holdings Limited annual cash flow from operations?
- What is the all time high annual CFO for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited annual CFO year-on-year change?
What is Regencell Bioscience Holdings Limited annual cash flow from operations?
The current annual CFO of RGC is -$4.00 M
What is the all time high annual CFO for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high annual cash flow from operations is -$391.00 K
What is Regencell Bioscience Holdings Limited annual CFO year-on-year change?
Over the past year, RGC annual cash flow from operations has changed by +$961.20 K (+19.37%)